Home / Inspections / 1067923

FDA Inspection 1067923 — Neos Therapeutics, LP

Neos Therapeutics, LP — FEI 3000205839

The FDA completed an inspection of Neos Therapeutics, LP on September 7, 2018 in Grand Prairie, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 7, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Grand Prairie, TX (United States)

Facility

Other inspections at this facility

  • 1219358 (VAI Fri Aug 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1021339 (VAI Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 929403 (VAI Thu Jun 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 730235 (VAI Fri May 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 648165 (VAI Fri Feb 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources